Roger A. Wood

United States Air Force Medical ...Wright-Patterson Afb, Ohio - 45433-5529 (937-257-9133) |
- CLINICAL TRIALS 16
- CONDITIONS32
- INTERVENTIONS40
- SINCE2005

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012

Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
April 2009 - August 2011

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

American Ginseng in Treating Patients With Fatigue Caused by Cancer
October 2008 - October 2010

Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015

Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
October 2009 - October 2010

Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
March 2010 - January 2020

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Hot Flashes
Myelodysplastic Syndromes
Preleukemia
Fatigue
Carcinoma, Non-Small-Cell Lung
Bone Neoplasms
Bone Marrow Diseases
Nausea
Vomiting
Neurotoxicity Syndromes
Precancerous Conditions
Myeloproliferative Disorders
Colorectal Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Lymphoproliferative Disorders
Osteonecrosis
Gabapentin
Placebo
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Zoledronic Acid
Celecoxib
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Pemetrexed Disodium
Oxaliplatin
Doxorubicin Hydrochloride
Dexamethasone
Polymerase Chain Reaction
Rosuvastatin
Mutation Analysis
Cetuximab
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Irinotecan Hydrochloride
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Ac Regimen
Duloxetine Hydrochloride
Vinorelbine Ditartrate
American Ginseng
Flaxseed
Acetyl-L-Carnitine Hydrochloride
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique



